Xeltis raises €32 million to drive clinical development of world's most advanced restorative cardiovascular devices

Xeltis raises €32 million to drive clinical development of world's most advanced restorative cardiovascular devices New investors DaVita Venture Group and Invest-NL join syndicate of international

Related Keywords

China ,United States ,Netherlands ,Dennis Riedl ,Alexander Goemans ,Amber Fennell Chris Welsh ,Steve Phillips ,Eliane Schutte ,Frank Zhou ,Health Economics Fund ,Davita Venture Group ,Pharma Group ,Life Sciences ,Group Vice ,Consilium Strategic Communications ,Grand Pharma ,Economics Fund ,Greater China ,Group Vice President ,Grand Pharmaceutical Group ,Kidney Disease ,Kurma Partners ,Ysios Capital ,Grand Pharma Group ,Exeltis ,Raises ,Billion ,Drive ,Linical ,Development ,World ,Most ,Dvanced ,Restorative ,Ardiovascular ,Devices ,